Overview of main clinical studies for MASLD/MASH with GLP-1 receptor agonists and dual or triple agonists targeting glucagon/GIP/GLP-1 receptors Liraglutide Liraglutide, a once-daily GLP-1 receptor agonist with authorized indications for type 2 diabetes and obesity, was evaluated in the LEAN trial (NCT01237119), a phase 2 randomized controlled study enrolling 52 adults with biopsy-proven MASH [22]
Medications Prescriptions (including GLP-1 medications) are filled through pharmacies and vary based on: Insurance coverage Medication type (Wegovy, Zepbound, etc.) Availability Well help you choose the most effective and cost-conscious option
Leung, T
Supplements should be viewed as adjuncts at most, not primary interventions
Why I Recommend InfiniWell BPC-157 Supports joint, tendon, and soft tissue recovery Helps improve gut health and digestive repair Encourages circulation, focus, and full-body recovery Helpful for active lifestyles, chronic stress, and movement recovery Their Rapid Pro formula supports faster recovery, while Delayed Pro is ideal for long-term healing and maintenance